SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Kosan BioSciences -- KOSN

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (888)2/29/2008 4:15:02 PM
From: tuck  Read Replies (1) of 933
 
>>Actually, I was serious. With composition of matter (from your notes of the CC), I should have said "relative" weakness.

So company "F" (for "Formulation King) would have three shots on goal, instead of one (or two/two, etc.).<<

Perhaps, but that seems unlikely to me, as I don't think there's much differentiation in the underlying compounds, particularly if it is Conforma/Biogen that is "F".

>>Anyway, a few more grunts and you'll be up 10% in a couple of days.<<

I settled for my one grunt and 6% in one day, which seems to have been a good move, so far. My Mom, OTOH, has been a long term holder at 3 bucks and change, so I'm certainly pulling for Tanespimycin to make it.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext